What topics does this cannabis study cover?

This study covers research on: Neuroprotection, Endocannabinoid, Mental Health.

Where was this research published?

Published in European journal of pharmacology on June 1, 2026.

Neuroprotection Endocannabinoid Mental Health

Omega-3 supplements reverse THC damage in developing brains

PERINATAL LC-ω-3-PUFA SUPPLEMENTATION OFFSETS PRENATAL THC-INDUCED COGNITIVE DEFICIT VIA SEX-SPECIFIC MODULATION OF HIPPOCAMPAL NEUROPLASTICITY.

European journal of pharmacology • June 1, 2026 • Moderately Relevant

🤖

AI Summary

Prenatal cannabis exposure has long been a concern for fetal development, but this study reveals a promising protective strategy. Researchers found that omega-3 fatty acid supplementation during pregnancy and lactation can prevent cognitive damage caused by prenatal THC exposure in offspring. The study used pregnant rats exposed to THC throughout gestation, with some receiving omega-3-enriched diets. When tested as adolescents, offspring who received the omega-3 supplementation showed fully restored memory function compared to those without it, demonstrating the protective power of nutritional intervention.

The mechanism behind this protection involves the endocannabinoid system (ECS), the brain's regulatory network that controls development and learning. THC disrupts this system by creating an imbalance in lipid molecules and triggering sex-specific changes in brain plasticity. Males showed restoration through rebalancing excitatory signals, while females recovered through reducing inhibitory signals—both achieving the same cognitive outcome through different biological pathways. The study identified specific genes and enzymes involved in these recovery mechanisms, including CB1R, NR1, and mGluR5, which regulate synaptic communication.

These findings have significant implications for pregnant women concerned about cannabis exposure and for the broader scientific understanding of nutritional interventions in developmental health. The research suggests that omega-3 supplementation is a safe, evidence-based nutritional strategy that could mitigate one of cannabis's most concerning risks: prenatal cognitive effects. This work opens new possibilities for preventive medicine while highlighting how dietary composition can interact with cannabis's effects on the developing brain.

📄 Original Abstract

Long-chain polyunsaturated fatty acids (LC-PUFAs) are crucial for brain development, with ω-3 species supporting neuronal membrane architecture, synaptogenesis and cognitive maturation, and ω-6 species linking lipid metabolism to neuronal signalling via the endocannabinoid system (ECS), the network of receptors, lipid mediators, and enzymatic pathways that orchestrate neurodevelopmental processes. Prenatal exposure to Δ9-tetrahydrocannabinol (THC), the psychoactive component of cannabis, impairs memory and disrupts hippocampal plasticity markers affecting the excitatory/inhibitory (E/I) balance, in a sex-dependent manner. This dysregulation is closely associated with a lipid shift favouring ω-6-derived mediators, leading to ECS imbalance. We investigated whether perinatal LC-ω-3-PUFA supplementation could prevent prenatal THC-induced neurodevelopmental deficits. Pregnant rats received THC (2 mg/kg, gestational days 5-20) and either a standard or LC-ω-3-PUFA-enriched diet (ω-3/ω-6 ratio = 1.4) from gestation through lactation. Adolescent offspring were evaluated for hippocampus-dependent memory (Novel object recognition) and gene expression of hippocampal plasticity markers (NR1, mGluR5, CB1R, NLgn-1/2/3) and endocannabinoid metabolising enzymes (DAGLα, NAPE-PLD, MAGL, FAAH). LC-ω-3-PUFAs prevented prenatal THC-induced memory impairment in both sexes. Molecular analyses revealed sex-specific recovery mechanisms. In males, LC-ω-3-PUFAs counteracted prenatal THC-induced synaptic hyperexcitability by restoring NR1, mGluR5, and CB1R expression, reducing Nlgn-1 and enhancing the Nlgn-3 levels, together with increased NAPE-PLD expression. In females, LC-ω-3-PUFAs rebalanced the prenatal THC-induced predominant inhibitory shift by reducing Nlgn-2/-3- and NAPE-PLD expression levels. These findings identify perinatal LC-ω-3-PUFA supplementation as a safe, effective nutritional strategy to counteract THC-induced neurodevelopmental vulnerability by restoring ECS balance and supporting sex-specific neuronal plasticity and cognitive integrity.

Paper Type

📄 Research

Publication

Journal: European journal of pharmacology
Published: June 1, 2026
PMID: 42229740
DOI: 10.1016/j.ejphar.2026.179064

Authors (8)

Gianluca Lavanco Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, Palermo, Italy. Electronic address: gianluca.lavanco@unipa.it.
Valentina Castelli Department of Biomedicine, Neuroscience and advanced Diagnostics, University of Palermo, Palermo, Italy. Electronic address: valentina.castelli02@unipa.it.
Cesare D'Amico Department of Biomedicine, Neuroscience and advanced Diagnostics, University of Palermo, Palermo, Italy. Electronic address: cesare.damico@unipa.it.
Salvatore Feo Department of Biological, Chemical and Pharmaceutical Sciences Technologies, University of Palermo, Palermo, Italy; ATEN Center, University of Palermo, Palermo, Italy. Electronic address: salvatore.feo@unipa.it.
Martin Kuchar Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague, Czechia; Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia. Electronic address: martin.kuchar@vscht.cz.
+3 more authors